HIV Prevention Strategies with Lenacapavir Injection

In a decision that could fundamentally reshape the fight against HIV, the US Food and Drug Administration (FDA) has given its approval to Gilead Sciences’ lenacapavir, a groundbreaking twice-yearly injection for preventing HIV infection in adults and adolescents. Marketed under the brand name Yeztugo in the US, this innovative drug has been eagerly anticipated by…...

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here

African Pharmaceutical Procurement: A Path to Self-Sufficiency

A pooled system for African pharmaceutical procurement is crucial. Africa must reduce its dependence on imported medicines. Delegates at a G20 event reached this conclusion. The discussion highlighted Africa’s vulnerability in its supply chain. The COVID-19 pandemic exposed this. Recent US and European aid cuts emphasised this. The Need for African Pharmaceutical Procurement Africa’s lack…...

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here